Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Chemotherapy|February 18, 2012
The qualification of docetaxel or erlotinib for second-line therapy should be based on clinical and molecular predictive factorsPaweł Krawczyk, Dariusz M Kowalski, Kamila Wojas-Krawczyk, et al.
Molecules (Basel, Switzerland)|December 30, 2020
A Chemometry of <i>Aldrovanda vesiculosa</i> L. (Waterwheel, Droseraceae) PopulationsBartosz J Płachno, Maciej Strzemski, Sławomir Dresler, et al.
Anticancer Research|July 2, 2014
Rare co-existence of mutation in KRAS and ALK gene re-arrangement in an adenocarcinoma patient--a case reportIwona Homa, Marek Sawicki, Kamila Wojas-Krawczyk, et al.
Frontiers in Pharmacology|June 30, 2017
<i>In Vitro</i> Antiproliferative Activity of Extracts of <i>Carlina acaulis</i> subsp. <i>caulescens</i> and <i>Carlina acanthifolia</i> subsp. <i>utzka</i>Maciej Strzemski, Kamil Wojnicki, Ireneusz Sowa, et al.
Oncotarget|October 4, 2017
Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of <i>EGFR</i> and <i>ALK</i> genesPaweł Krawczyk, Bożena Jarosz, Tomasz Kucharczyk, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|August 8, 2018
Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary studyKamila Wojas-Krawczyk, Ewa Kalinka-Warzocha, Katarzyna Reszka, et al.
Oncology Reports|June 21, 2013
Predictive and prognostic factors in second- and third-line erlotinib treatment in NSCLC patients with known status of the EGFR genePaweł Krawczyk, Dariusz M Kowalski, Kamila Wojas Krawczyk, et al.
BMC Infectious Diseases|August 26, 2024
Immunological insights: assessing immune parameters in medical professionals exposed to SARS-CoV-2Kamila Wojas-Krawczyk, Paweł Krawczyk, Justyna Błach, et al.
Scientific Reports|October 23, 2021
Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangementPaweł Krawczyk, Anna Grenda, Paulina Terlecka, et al.
Journal of Applied Genetics|January 3, 2026
When genetics meets immunology: the assessment of genetic and immunological backgrounds in advanced NSCLC patients treated with immunotherapy - preliminary studyNatalia Krzyżanowska, Marcin Nicoś, Kamila Wojas-Krawczyk, et al.
Pageof 7